Japanese Pharmacopoeia 18th Edition - English Version Now Available

Recommendation
6/7 May 2025
Challenges and Solutions for Packaging / Devices & Single Use Systems
The English translation of the Japanese Pharmacopoeia (JP) 18th edition is available for download free of charge.
Legal Status
The Japanese Pharmacopoeia is the pharmaceutical standard that the Japanese Minister of Health, Labour and Welfare (MHLW) establishes to regulate the properties and quality of drugs.
As with other pharmacopoeias, the document is revised periodically. The 18th edition (JP18) came into effect on June 7, 2021. The text is originally prepared in Japanese and translated to English after the publication of the Japanese version. This usually is done within one year. According to the publication schedule, Supplement I to JP18 is to be published in December 2022 and Supplement II in 2024. It is planned that the 19th edition will be published in 2026.
Content of JP18 English Version
The following documents are available as PDF files:
- General Notice - General Tests, Processes and Apparatus
- Official Monographs (A to L)
- Official Monographs (M to Z)
- Crude Drugs and Related Drugs
- Infrared Reference Spectra
- Ultraviolet-visible Reference Spectra
- General Information
Download
The English translation of the 18th version is available free of charge on the website of the Minister of Health, Labour and Welfare. There you will also find the older editions of the pharmacopoeia.
Further information is also available in the JP Frequently Asked Questions section.
Related GMP News
06.03.2025Eurachem publishes Leaflet on Analytical Equipment and Systems
06.03.2025Further Modifications to USP Chapter <621> Chromatography Published for Comment
06.03.2025Proposed Update to USP <1058> on Analytical Instrument and System Qualification
26.02.2025FDA Warning Letter Highlights Responsibilities of Contract Testing Laboratories
26.02.2025New ISO/TR 33402:2025 on Reference Material Preparation
19.02.2025FDA Warning Letter: Chinese API Manufacturer on Import Alert Due to CGMP Violations